Literature DB >> 11914930

Primary hyperparathyroidism in MEN 1--how radical should surgery be?

Johnathan G H Hubbard1, Frédéric Sebag, Sylvie Maweja, Jean-François Henry.   

Abstract

Primary hyperparathyroidism is the most common manifestation of MEN 1 syndrome. The management of these patients is complex due to the underlying disease process, which predisposes patients to persistent and recurrent disease. The surgical treatment of patients with MEN 1 and hyperparathyroidism can therefore be considered to be palliative in nature. The basic principles of surgery include (1) obtaining and maintaining normocalcaemia for the longest time possible, avoiding persistent/recurrent hypercalcaemia, (2) avoiding surgically induced hypocalcaemia, and (3) facilitating future surgery for recurrent disease. Two approaches have been described as the best practice for patients with hyperparathyroidism in MEN 1: subtotal parathyroidectomy, leaving a remnant of no more than 60 mg in the neck, and total parathyroidectomy with immediate autotransplantation of 10-20 1 mm(3) pieces of parathyroid tissue. Both approaches should be combined with efforts to exclude supernumerary glands and ectopic parathyroid tissue by including resection of fatty tissue from the central neck compartment and thymectomy in all patients. Cryopreservation of parathyroid tissue should be performed whenever facilities are available. In patients with persistent or recurrent disease, an attempt to obtain total elimination of cervical parathyroid tissue is justified, combined with cryopreservation of parathyroid tissue. As radical as surgery is for hyperparathyroidism in MEN 1, the surgeon must take steps to avoid permanent hypoparathyroidism, which in young patients may be worse than the disease itself.

Entities:  

Mesh:

Year:  2002        PMID: 11914930     DOI: 10.1007/s00423-002-0275-0

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  8 in total

1.  Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?

Authors:  Naris Nilubol; Lee Weinstein; William F Simonds; Robert T Jensen; Giao Q Phan; Marybeth S Hughes; Steven K Libutti; Stephen Marx; Electron Kebebew
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

Review 2.  The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review.

Authors:  Jennifer M J Schreinemakers; Carolina R C Pieterman; Anouk Scholten; Menno R Vriens; Gerlof D Valk; Inne H M Borel Rinkes
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

3.  Primary hyperparathyroidism in the young age group: particularities of diagnostic and therapeutic schemes.

Authors:  Kenko Cupisti; Andreas Raffel; Cornelia Dotzenrath; Markus Krausch; Hans-Dietrich Röher; Klaus-Martin Schulte
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

4.  Multiple endocrine neoplasia type 1 parathyroid adenoma development over time.

Authors:  Gerard M Doherty; Terry C Lairmore; Mary K DeBenedetti
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

5.  Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.

Authors:  Jeffrey A Norton; David J Venzon; Marc J Berna; H R Alexander; Douglas L Fraker; Stephen K Libutti; Stephen J Marx; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

6.  [Multiple endocrine neoplasia type 1. Surgical therapy of primary hyperparathyroidism].

Authors:  P Langer; A Wild; T Schilling; C Nies; M Rothmund; D K Bartsch
Journal:  Chirurg       Date:  2004-09       Impact factor: 0.955

Review 7.  Persistent and recurrent hyperparathyroidism.

Authors:  Nadine R Caron; Cord Sturgeon; Orlo H Clark
Journal:  Curr Treat Options Oncol       Date:  2004-08

Review 8.  Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: experience from a single academic center.

Authors:  Fabio Luiz de Menezes Montenegro; Delmar Muniz Lourenço; Marcos Roberto Tavares; Sergio Samir Arap; Climerio Pereira Nascimento; Ledo Mazzei Massoni Neto; André D'Alessandro; Rodrigo Almeida Toledo; Flávia Lima Coutinho; Lenine Garcia Brandão; Gilberto de Britto e Silva Filho; Anói Castro Cordeiro; Sergio Pereira Almeida Toledo
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.